Compumedics (CMP) Fundamentals 2026 — P/E 575.0x, Revenue Analysis | SniperIQ
Compumedics (CMP) is a AU-listed Healthcare company in Medical - Devices with a market capitalization of A$46M, trading at A$0.23 on the ASX. This SniperIQ fundamentals page covers Compumedics's valuation (P/E 575.0x, P/B 2.0x), profitability (net margin 0.2%), revenue (A$51M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Compumedics's market cap?
Compumedics (CMP) has a market capitalization of approximately A$46M, trading at A$0.23 on the ASX. Market cap moves with the live share price.
What is Compumedics's P/E ratio?
Compumedics's trailing twelve-month P/E ratio is 575.0x, with a price-to-book (P/B) of 2.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Compumedics?
Compumedics runs a net profit margin of 0.2%, a gross margin of 58.3%, and an operating margin of 4.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Compumedics generate?
Compumedics reported revenue of A$51M for fiscal year 2025, with net income of -A
Does Compumedics pay a dividend?
Compumedics does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Compumedics financially healthy?
Compumedics carries a debt-to-equity ratio of 0.60x and a current ratio of 1.15x, with a market beta of 0.37. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Compumedics a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Compumedics (CMP) the key facts are: market cap A$46M, P/E 575.0x, revenue A$51M, 52-week range 0.215-0.45. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Compumedics's full fundamentals live
Get Compumedics's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.